Welcome to our dedicated page for Elevance Health news (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health stock.
Elevance Health, Inc. (NYSE: ELV) generates a steady stream of news as a major participant in the direct health and medical insurance carriers industry. Company updates frequently focus on financial performance, member experience initiatives, digital tools, and community health programs. Investors and observers following ELV news can see how Elevance Health communicates its strategy as a lifetime, trusted health partner serving over 109 million consumers through medical, pharmacy, behavioral, clinical, home health, and complex care solutions.
News coverage often includes earnings results and guidance, such as quarterly financial releases that detail segment performance for Health Benefits and Carelon, membership trends across commercial, Medicare, Medicaid, and Federal Employee Program lines, and commentary on benefit expense ratios and operating metrics. The company also issues announcements about upcoming conference calls and webcasts where management reviews results and outlook with investors.
Another key theme in Elevance Health news is the evolution of the healthcare consumer experience. Articles describe AI-enabled digital solutions, including the Virtual Assistant available through the Sydney Health app, which helps members understand benefits, compare costs, and find in-network providers. The company also highlights care management programs, concierge-style support for serious illnesses, and models such as “My Health Advocate” in affiliated Medicare plans.
Elevance Health news frequently covers whole-health and community initiatives. Examples include Food as Medicine partnerships with the National Association of Community Health Centers, school-based fitness facility upgrades, and expanded access to doula care and social supports in certain Medicare Advantage and Medicaid plans. Governance developments, such as the appointment of independent directors to the board and related committee assignments, are also reported through press releases and SEC-linked announcements.
By reviewing the ELV news feed on this page, readers can follow financial disclosures, strategic initiatives, digital and clinical innovations, and community-focused programs that shape Elevance Health’s role in the health benefits and healthcare services landscape.
Continental General Insurance Company announced a definitive agreement to acquire a block of long-term care policies from Elevance Health (NYSE: ELV). This strategic move represents one of the few successful long-term care transactions in a decade, aimed at enhancing Continental General's TPA services. The acquisition furthers Continental General's mission to become a leading acquisition partner in the long-term care sector. The deal, set to close on April 3, 2023, will leverage Continental General’s over 60 years of insurance management experience for policyholders.
The Advancing Health Together: Progress Report from Elevance Health (NYSE: ELV) highlights its partnerships with care providers to enhance health access, outcomes, and affordability. The report reveals that 80% of a person’s health is influenced by factors beyond the doctor's office, prompting Elevance Health to utilize its extensive data to support care providers. Currently, Elevance serves over 47.5 million Americans and manages more than 1.7 million care provider relationships nationwide. The company emphasizes the importance of collaboration in achieving measurable improvements in whole health.
The Standard has announced a definitive agreement to acquire Elevance Health's Life & Disability business. This strategic move combines the strengths of both companies, emphasizing their commitment to customer service and benefits administration. The Standard will operate under its brand, incorporating Elevance's employees and operations. The partnership aims to enhance distribution channels, bringing additional life and disability insurance products to customers. Upon closing, The Standard will gain access to Elevance's portfolio, serving approximately 4.8 million covered lives in 14 states, thereby accelerating its growth and market presence in the U.S.
Anthem Blue Cross and Blue Shield in Georgia has launched Virtual-First health plans, providing eligible members with affordable access to virtual care options. The plans include an AI-driven symptom checker and support for chronic condition management. Starting from July 2023, these plans aim to improve healthcare experiences by seamlessly connecting virtual and in-person care through the Sydney Health app, available 24/7. Members benefit from various cost-share options, potentially including no coinsurance for virtual care. These services will also cater to national account ASO clients beginning January 1, 2024.
Elevance Health (NYSE: ELV) will host an Investor Conference on March 23, 2023, in New York City. The event features presentations and Q&A sessions with senior leadership, webcast live from 8:00 a.m. ET to 12:00 p.m. ET. Interested parties can register for the webcast here or visit ElevanceHealth.com. Presentations will be available for download later on the website.
AM Best has affirmed the Financial Strength Rating (FSR) of A- (Excellent) and a Long-Term Issuer Credit Rating of 'a-' (Excellent) for WellPoint Insurance Services, Inc. (WISI), a wholly owned subsidiary of org value="NYSE:ELV"Elevance Health. The outlook remains stable. WISI’s balance sheet strength is deemed adequate, with improved risk-adjusted capitalization but a projected decline in 2022 due to reserve strengthening and unrealized losses. WISI's core operations, particularly in the Federal Employees Health Benefits Program, remain strong, although operating results in other business lines have fluctuated.
Elevance Health released a study indicating that individuals experiencing long COVID face significantly higher risks for various adverse cardiovascular and pulmonary conditions, as well as increased mortality rates compared to those without COVID-19.
The study, the largest of its kind involving 13,435 long COVID patients, highlights that:
- 2.35 times more likely to experience cardiac arrhythmias
- 3.64 times more likely to face pulmonary embolism
- 2.8% mortality rate in long COVID patients versus 1.2% in non-COVID patients
This highlights a need for better care management programs to address these risks.
Elevance Health (NYSE: ELV) has finalized its acquisition of BioPlus, a notable specialty pharmacy, enhancing its capabilities in managing complex health conditions. This strategic move focuses on providing comprehensive pharmacy services across all 50 states, particularly for patients with chronic ailments like cancer and multiple sclerosis. The integration of BioPlus into Elevance’s CarelonRx will enable improved accessibility and affordability of specialty drugs, aiming to elevate patient care and experience. Elevance plans to expand BioPlus’ service models, aligning with its commitment to holistic healthcare solutions.
Elevance Health, Inc. (NYSE: ELV) announced that from October 15, 2022, its 2.750% Senior Convertible Debentures due 2042 will accrue a contingent interest of 0.50% per annum based on the average trading price over the preceding ten days. This translates to approximately $16.8123 per Note, payable on April 15, 2023, to record holders as of April 1, 2023. The company serves over 119 million individuals through various healthcare services, emphasizing its commitment to improving health outcomes.
Elevance Health reported strong financial results for Q4 and the full year 2022, with GAAP net income of $3.93 and $24.81 per share, respectively. Adjusted net income was $5.23 and $29.07 per share. Operating revenue increased 13.7% year-over-year to $156 billion, and operating gain grew 12.9% to $8.5 billion. Medical enrollment rose by 2.2 million members to 47.5 million. A quarterly dividend increased by 16% to $1.48 per share. For 2023, the company anticipates GAAP net income exceeding $29.80 per share. These results reflect Elevance’s progress towards becoming a trusted health partner, with strategic advances to optimize their businesses.